谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Abstract CT028: Fixed-duration (FD) Ibrutinib (ibr) + Venetoclax (ven) for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) in Patients (pts) with High-Risk Features: Phase 2 CAPTIVATE Study

John N. Allan,Ian W. Flinn,Tanya Siddiqi,Paolo Ghia,Constantine S. Tam,Thomas J. Kipps,Paul M. Barr,Anna Elinder Camburn,Alessandra Tedeschi,Xavier C. Badoux,Ryan Jacobs,Bryone J. Kuss,Livio Trentin,Cathy Zhou,Anita Szoke,Maoko Naganuma,William G. Wierda

Cancer Research（2022）

引用 0|浏览20
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要